Literature DB >> 21847637

The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients.

Kristina Rue Nielsen1, Annette H Chakera, Birger Hesse, Richard A Scolyer, Jonathan F Stretch, John F Thompson, Michael B Nielsen, Roger F Uren, Peter S Oturai.   

Abstract

PURPOSE: The aim of this study was to compare early dynamic imaging combined with delayed static imaging and single photon emission computed tomography (SPECT)/CT with delayed, planar, static imaging alone for sentinel node (SN) identification in melanoma patients.
METHODS: Three hundred and seven consecutive melanoma patients referred for SN biopsy (SNB) were examined using combined imaging. Secondary interpretation of only the delayed static images was subsequently performed. In 220 patients (72%), complete surgical and pathological information relating to the SNB was available. The number of SNs identified and number of patients with positive SNs were compared between the two interpretations of the imaging studies and, when available, related to pathology data.
RESULTS: A slightly higher number of SNs (mean 0.12/patient) was identified when interpreting only delayed static images compared to combined imaging. In a direct patient-to-patient comparison, the number of SN(s) identified on the combined vs static images only showed moderate agreement (kappa value 0.56). In 38 patients (17%), positive SNs were identified by the combined procedure compared to 35 (16%) by static imaging only. Thus by static imaging only, tumour-positive SNs were not identified in 3 of 38 patients (8%).
CONCLUSION: For SN identification in melanoma patients, dynamic imaging combined with delayed static imaging and SPECT/CT is superior to delayed static imaging only because the latter is more likely to fail to identify SNs containing metastases.

Entities:  

Mesh:

Year:  2011        PMID: 21847637     DOI: 10.1007/s00259-011-1880-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  14 in total

1.  Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0.

Authors:  Naomi Alazraki; Edwin C Glass; Frank Castronovo; Renato A Valdés Olmos; Donald Podoloff
Journal:  J Nucl Med       Date:  2002-10       Impact factor: 10.057

2.  SPECT/CT Lymphoscintigraphy to locate the sentinel lymph node in patients with melanoma.

Authors:  Roger F Uren
Journal:  Ann Surg Oncol       Date:  2009-04-11       Impact factor: 5.344

3.  Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes.

Authors:  J F Thompson; W H McCarthy; C M Bosch; C J O'Brien; M J Quinn; S Paramaesvaran; K Crotty; S W McCarthy; R F Uren; R Howman-Giles
Journal:  Melanoma Res       Date:  1995-08       Impact factor: 3.599

4.  Sentinel-node biopsy or nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

Review 5.  Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data.

Authors:  Yoichi Moroi
Journal:  Int J Clin Oncol       Date:  2009-12-05       Impact factor: 3.402

6.  The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma.

Authors:  Iris M C van der Ploeg; Renato A Valdés Olmos; Bin B R Kroon; Michael W J M Wouters; Michiel W M van den Brekel; Wouter V Vogel; Cornelis A Hoefnagel; Omgo E Nieweg
Journal:  Ann Surg Oncol       Date:  2009-01-29       Impact factor: 5.344

Review 7.  Pathologic examination of sentinel lymph nodes from melanoma patients.

Authors:  Richard A Scolyer; Rajmohan Murali; Stanley W McCarthy; John F Thompson
Journal:  Semin Diagn Pathol       Date:  2008-05       Impact factor: 3.464

8.  Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic.

Authors:  D L Morton; L Wanek; J A Nizze; R M Elashoff; J H Wong
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

9.  Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node.

Authors:  R F Uren; R B Howman-Giles; H M Shaw; J F Thompson; W H McCarthy
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

10.  Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CT-scans allow mapping of aberrant pelvic sentinel lymph nodes in malignant melanoma.

Authors:  L Kretschmer; G Altenvoerde; J Meller; M Zutt; M Funke; C Neumann; W Becker
Journal:  Eur J Cancer       Date:  2003-01       Impact factor: 9.162

View more
  2 in total

1.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

2.  Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma: study protocol for a multicentric randomized controlled trial.

Authors:  Ingo Stoffels; Ken Herrmann; Jan Rekowski; Philipp Jansen; Dirk Schadendorf; Andreas Stang; Joachim Klode
Journal:  Trials       Date:  2019-02-04       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.